JG
CRL icon

Jefferies Group’s Charles River Laboratories CRL Stock Holding History

Jefferies Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-26,000
Closed -$9.62M – 1756
2021
Q2 		$9.62M Hold
26,000
– – 0.06% 284
2021
Q1 		$7.54M Buy
26,000
+1,000
+4% +$278K 0.07% 258
2020
Q4 		$6.25M Buy
+25,000
New +$5.95M 0.05% 334

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Jefferies Group's CRL Position: Q3 2022 in Review

Jefferies Group opened a new position in Charles River Laboratories (CRL) in Q3 2022: 3,122 shares worth $614K. The stake represents 0.01% of the portfolio and ranks #968 among its holdings. This is a return to the name: Jefferies Group previously reported a position in CRL as recently as Q2 2021.

Jefferies Group first reported a position in CRL in Q3 2013 and has held it in 27 quarters since. The position peaked at $11.1M in Q1 2021. 583 funds tracked by Wall St. Rank hold CRL as of Q3 2022.

  • Jefferies Group held 3,122 shares of Charles River Laboratories worth $614K as of Q3 2022.
  • Charles River Laboratories was a new Jefferies Group position in Q3 2022.
  • Charles River Laboratories made up 0.01% of Jefferies Group's portfolio in Q3 2022, its #968 holding.
  • Jefferies Group first reported a position in Charles River Laboratories in Q3 2013 and has held it in 27 quarters since.
  • Jefferies Group's Charles River Laboratories position peaked at $11.1M in Q1 2021.
  • 583 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.